SCHEMBL8208595

SCHEMBL8208595

CN1CCCC1Cc1cn(S(=O)(=O)c2ccc(F)cc2)c2ccc(Cl)cc12

nearest known ligand 0.82

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 20/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8213978 1.00 HTR6 (0.82) HTR6
SCHEMBL8209520 0.90 HTR6 (1.00) HTR6
SCHEMBL8209518 0.90 HTR6 (1.00) HTR6
SCHEMBL8201578 0.89 HTR6 (0.79) HTR6
SCHEMBL8201580 0.89 HTR6 (0.79) HTR6
SCHEMBL8209793 0.87 HTR6 (0.75) HTR6
SCHEMBL8209790 0.87 HTR6 (0.75) HTR6
SCHEMBL8201520 0.86 HTR6 (0.84) HTR6
SCHEMBL8201522 0.86 HTR6 (0.84) HTR6
SCHEMBL7472988 0.80 HTR6 (0.75) HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6100291-A FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS ALLELIX BIOPHARMACEUTICALS INC. (CA) 2000-08-08 US claimed
WO-1999047516-A1 3-(2-PYRROLIDINYLMETHYL)-INDOLE COMPOUNDS HAVING 5-HT6 AFFINITY SLASSI ABDELMALIK (CA) 1999-09-23 WO claimed
US-6100291-A FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS ALLELIX BIOPHARMACEUTICALS INC. (CA) 2000-08-08 US disclosed
WO-1999047516-A1 3-(2-PYRROLIDINYLMETHYL)-INDOLE COMPOUNDS HAVING 5-HT6 AFFINITY SLASSI ABDELMALIK (CA) 1999-09-23 WO disclosed